“It’ll be a jackpot to launch Champix generic,’ leading patent challenges

Published: 2016-09-23 16:29:00
Updated: 2016-09-23 09:48:48

Since Pfizer’s antismoking treatment, ‘Champix(varenicline tartrate)’ become a gigantic product with the government’s drug price support, Korean pharmaceutical companies have tried to launch its generic.

However, its patent valid until July 19, 2020, has interrupted the hope of the companies.

...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.

Original Korean




Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.